Personalized synthetic genome design
Genome Compiler has raised €5.8M across 2 funding rounds from 1 investor, most recently a Series A round in Jun 2015. Based in Tel Aviv, Israel; founded 2011; active in Healthtech. Acquired by Twist Bioscience in 2016. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-06-01 | Series A | €5.8M | — | View deal → |
| 2013-10-01 | Seed | €0 | Techammer | View deal → |
